STAAR Surgical (STAA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
STAAR Surgical Reports First Quarter 2015 Results
April 29, 2015 4:01 PM EDTMONROVIA, Calif., April 29, 2015 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today reported financial results for the first quarter ended April 3, 2015.
First Quarter Overview
Net Sales of $18.9 Million Decreased 7% from the Year Ago Period and 3% on a Constant Currency Basis ICL Units in North America Increased 18% and EMEA Units Increased 9% CentraFLOW® Accounted for 78% of ICL Shipments in China Gross Margin Increased to 68% in Q1 vs. 57% in Q4 2014... More


